Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biotechnology Journal|June 8, 2012
Monitoring ceramic hydroxyapatite media degradation using dynamic image analysis and uniaxial confined bulk compressionOliver Kaltenbrunner, Shawn Cao, Esteban Freydell, et al.Mabs|March 20, 2018
Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumabNeungseon Seo, Alla Polozova, Mingxuan Zhang, et al.Protein Science : a Publication of the Protein Society|January 30, 2009
Ion-specific modulation of protein interactions: anion-induced, reversible oligomerization of a fusion proteinYatin R Gokarn, R Matthew Fesinmeyer, Atul Saluja, et al.Journal of Pharmaceutical Sciences|October 20, 2019
Silicone Oil Particles in Prefilled Syringes With Human Monoclonal Antibody, Representative of Real-World Drug Products, Did Not Increase Immunogenicity in In Vivo and In Vitro Model SystemsNathan H Joh, Lisa Thomas, Twinkle R Christian, et al.Ophthalmology and Therapy|March 20, 2024
Analytical and Functional Similarity of Aflibercept Biosimilar ABP 938 with Aflibercept Reference ProductNeungseon Seo, Xiaoyan Guan, Tian Wang, et al.Journal of Pharmaceutical Sciences|January 14, 2024
Evaluating Clinical Safety and Analytical Impact of Subvisible Silicone Oil Particles in Biopharmaceutical ProductsMiguel Saggu, George M Bou-Assaf, Reinhard Bucher, et al.Journal of Pharmaceutical Sciences|October 25, 2019
A Multicompany Assessment of Submicron Particle Levels by NTA and RMM in a Wide Range of Late-Phase Clinical and Commercial Biotechnology-Derived Protein ProductsMario Hubert, Dennis T Yang, Stanley C Kwok, et al.Journal of Pharmaceutical Sciences|August 24, 2022
Industry Perspective on the Use and Characterization of Polysorbates for Biopharmaceutical Products Part 2: Survey Report on Control Strategy Preparing for the FutureKlaus Wuchner, Linda Yi, Cyrille Chery, et al.Journal of Pharmaceutical Sciences|February 22, 2022
Industry Perspective on the use and Characterization of Polysorbates for Biopharmaceutical Products Part 1: Survey Report on Current State and Common Practices for Handling and Control of PolysorbatesKlaus Wuchner, Linda Yi, Cyrille Chery, et al.Biologicals : Journal of the International Association of Biological Standardization|September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysisVincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.Pageof 3